New hope for breast cancer: personalized Pre-Surgery drug combo shows promise
Knowledge-focused
Completed
This study looked at whether adding a drug that targets specific genetic changes in breast tumors could slow cancer growth more than standard hormone therapy alone. It involved 19 people with ER-positive, HER2-negative breast cancer who received treatment before surgery. The goal…
Phase: PHASE2 • Sponsor: Jennifer Lee Caswell-Jin • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC